Klivira
Request demo

Streamlining CompuGroup (Aprima) Mounjaro Prior Authorization

Klivira automates the complex CompuGroup (Aprima) Mounjaro prior authorization process, integrating directly with your EMR to reduce administrative overhead and accelerate patient access to critical therapies.

Revenue cycle directors and prior authorization coordinators within ambulatory practices face significant challenges managing the increasing volume of PAs for high-cost medications like Mounjaro (tirzepatide). Manual workflows within CompuGroup (Aprima) for GIP/GLP-1 dual agonists can strain resources and delay care. Klivira provides a robust solution to streamline this critical process.

The Mounjaro PA Workflow within CompuGroup (Aprima)

When a Mounjaro (tirzepatide) prescription is initiated in CompuGroup (Aprima), the system typically flags it for prior authorization due to its drug class (GIP/GLP-1 dual agonist) and payer requirements. This often triggers a manual or semi-automated process involving form completion, documentation gathering, and submission. Klivira intercepts this workflow at the point of order, initiating an intelligent automation sequence tailored to Aprima's data structure.

Navigating Pharmacy Benefit PAs for Tirzepatide in Aprima

Mounjaro, as a prescription medication, falls under the pharmacy benefit for most payers. This necessitates electronic prior authorization (ePA) submissions via the NCPDP SCRIPT standard, rather than medical benefit X12 278 transactions. Klivira's integration with CompuGroup (Aprima) ensures that relevant prescription details are correctly identified and routed for ePA, bypassing common misclassifications that can occur in systems without specialized PA automation.

Klivira's Intelligent Data Extraction from Aprima for Mounjaro PAs

Successful Mounjaro prior authorizations require specific clinical documentation, including diagnosis confirmation (Type 2 Diabetes), past medication trials (step therapy), and relevant lab results (e.g., A1C). Klivira leverages CompuGroup (Aprima)'s CGM APIs to intelligently pull this critical data directly from patient charts, including problem lists, medication history, and discrete lab values. This eliminates the need for manual chart review, reducing errors and accelerating submission preparation.

Seamless Integration with CompuGroup (Aprima) via CGM APIs

Klivira establishes a secure, bi-directional integration with CompuGroup (Aprima) utilizing available CGM APIs. This allows for automated identification of Mounjaro prescriptions requiring PA, extraction of necessary clinical data, and updates on PA status directly within the Aprima EMR. This technical foundation ensures data integrity and a streamlined experience for providers and staff within ambulatory practices.

Optimizing Specialty Pharmacy Routing for Mounjaro

Many GIP/GLP-1 dual agonists like Mounjaro are dispensed through specialty pharmacies. Klivira's platform not only automates the prior authorization but also assists in identifying and routing prescriptions to the appropriate specialty pharmacy based on payer networks and patient preferences, all while maintaining visibility within the CompuGroup (Aprima) workflow. This comprehensive approach ensures continuity from prescription to dispense.

Frequently asked questions

How does Klivira specifically integrate with CompuGroup (Aprima) for Mounjaro prior authorizations?

Klivira integrates with CompuGroup (Aprima) using its documented CGM APIs. This allows our platform to securely access patient data, identify Mounjaro prescriptions requiring PA, extract necessary clinical documentation, and post PA status updates back into the Aprima EMR, automating key steps in the workflow.

What documentation does Klivira pull from Aprima to support Mounjaro PAs?

For Mounjaro (tirzepatide) prior authorizations, Klivira automatically extracts data from Aprima's problem list for diagnosis verification (Type 2 Diabetes), medication history for step therapy compliance, and discrete lab results such as A1C levels. This ensures all required clinical criteria are addressed without manual chart review.

Does Klivira handle the distinction between pharmacy and medical benefit PAs for Mounjaro within Aprima?

Yes, Klivira is designed to recognize that Mounjaro typically falls under the pharmacy benefit. Our system ensures that prior authorization requests are submitted via the correct ePA channels (NCPDP SCRIPT), aligning with payer requirements for pharmacy-dispensed medications and integrating seamlessly with Aprima's prescription management.

How does Klivira help with step therapy requirements for Mounjaro for Aprima users?

Klivira automates the verification of step therapy requirements by analyzing patient medication history within CompuGroup (Aprima). Our platform identifies if prior medications have been tried and failed, automatically populating this critical information into the prior authorization request to ensure compliance with payer protocols for Mounjaro.

Can Klivira help route Mounjaro prescriptions to specialty pharmacies from Aprima?

Yes, beyond prior authorization, Klivira can assist in the intelligent routing of Mounjaro prescriptions to appropriate specialty pharmacies. Our system can leverage payer-specific information and integrate with Aprima's prescription workflow to ensure the medication reaches the correct dispensing entity efficiently.

Related coverage

Other aprima prior auth coverage

Ready to automate prior auth for this integration?

See how Klivira automates prior authorizations for your team.

Request a demo